Effect of Zinc Acetate Dihydrate (NobelzinR) Treatment on Anemia and Taste Disorders in Patients with Chronic Kidney Disease with Hypozincemia

Some patients with chronic kidney disease (CKD) receiving hemodialysis develop erythropoietin-resistant anemia, possibly due to zinc deficiency. The frequency of zinc deficiency in CKD (stages 1-5 and 5D) and CKD improvement via zinc supplementation are not completely verified. Here 500 CKD patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta medica Okayama 2018-10, Vol.72 (5), p.535-538
Hauptverfasser:	Sato, Daisuke, Gohda, Tomohito, Kihara, Masao, Kanaguchi, Yasuhiko, Kobayashi, Takashi, Mano, Satoshi, Sasaki, Yu, Nohara, Nao, Murakoshi, Maki, Nakata, Junichiro, Suzuki, Hitoshi, Ueda, Seiji, Horikoshi, Satoshi, Suzuki, Yusuke
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anemia - drug therapy Cross-Sectional Studies Humans Middle Aged Renal Insufficiency, Chronic - blood Renal Insufficiency, Chronic - complications Taste Disorders - drug therapy Young Adult Zinc - blood Zinc - deficiency Zinc Acetate - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Some patients with chronic kidney disease (CKD) receiving hemodialysis develop erythropoietin-resistant anemia, possibly due to zinc deficiency. The frequency of zinc deficiency in CKD (stages 1-5 and 5D) and CKD improvement via zinc supplementation are not completely verified. Here 500 CKD patients (Stage 1/2, n=100; Stage 3, n=100; Stage 4, n=100, Stage n=5, 100; Stage 5D, n=100) will be recruited to determine the frequency of serum zinc deficiency at each CKD stage. Patients with serum zinc concentrations
ISSN:	0386-300X
DOI:	10.18926/AMO/56254